EUSA Pharma Competitors and Similar CompaniesClear all
Exscientia's competitors and similar companies include Immunomedics.
 Exscientia Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | |
Founding Date | Founding Date 2012 | Founding Date 1982 |
Type | Type Subsidiary | Type Subsidiary |
Tags | ||
Locations | Locations Oxford, GB HQ Wien, AT Osaka, JP Dundee, GB Miami, US | Locations Morris Plains, US HQ |
Employees | Employees 88 | Employees 8914% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) £20.1m (FY, 2023) | Revenue (est.) $295k (FY, 2019) |
Cost of goods | Cost of goods £10.5m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit £10.8m (FY, 2023) | Gross profit $295k (FY, 2019) |
Net income | Net income (£146m) (FY, 2023) | Net income ($357.3m) (FY, 2019) |
Funding | ||
Total funding raised | Total funding raised $ 430.2m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Immunomedics
HQ
Morris Plains, US
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View company